Adis Journals
Browse
- No file added yet -

Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis after Methotrexate failed in China

Download (121.08 kB)
figure
posted on 2021-04-22, 15:30 authored by Adis journals on behalf of, SiNi Li, JianHe Li, LiuBao Peng, XiaoMin Wan, YaMin Li

Article full text


The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2021.

History

Usage metrics

    Rheumatology and Therapy

    Categories

    Keywords

    Rheumatoid ArthritisBaricitinibCost-Effectiveness AnalysisModelJanus kinase Inhibitors

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC